CMC-SII20250525-01.pdfNutraceuticals as Source of Novel DrugsSimoneBrogiDecember2023CMC-SII20250525-01.pdfCMC-SII20230207-01.pdfPhytochemicals as Therapeutic Agents Against CancerAlok Chandra BhartiBharat B.AggarwalMay2023CMC-SII20230207-01.pdfCMC-SII20221209-01.pdfNovel anti-tumor bio-drugs and therapeutic strategies in cancer management: from bench to
translational research ShigaoHuangJun2023CMC-SII20221209-01.pdfCMC-SII20221130-02.pdfElectrochemical biosensors for multiplex assaysEdytaMikułaDecember2022CMC-SII20221130-02.pdfCMC-SII20221130-01.pdfInsights into Target-Based vs Phenotypic Approach: Opportunities and
ChallengesVaishali M.PatilLucianaScottiJanuary2023CMC-SII20221130-01.pdfCMC-SII20221117-01.pdfApplications of artificial intelligence in drug discovery and developmentWeiChenOctober2023CMC-SII20221117-01.pdfCMC-SII20221031-01.pdfA grandiose ubiquitous enzyme superfamily: Carbonic AnhydrasesAnnaArteseApr2023CMC-SII20221031-01.pdfCMC-SII20221019-01.pdfViral/Bacterial Targeting of Mitochondria: Novel Medicinal ApproachesPascalBüttikerGeorge BStefanoNovember2022CMC-SII20221019-01.pdfCMC-SII20220919-01.pdfComputational methods and artificial intelligence in therapeutic peptides discovery,
development and beyondJianHuangMarch2023CMC-SII20220919-01.pdfCMC-SII20220913-01.pdfTherapeutic challenges in the treatment of neurological diseasesTizianaLatronicoMarch2023CMC-SII20220913-01.pdfCMC-SII20220906-01.pdfProgress and challenges in the research of new agents directed against breast cancer
CristinaMaccalliniDecember2022CMC-SII20220906-01.pdfCMC-SII20220810-02.pdfCHALLENGES OF NATURAL ANTICANCER AND ANTI-INFLAMMATORY AGENTSLucianaScottiMarcus T.ScottiOctober2022CMC-SII20220810-02.pdfCMC-SII20220810-01Targeting Cysteine and Serine Proteases to Discover New Drugs Against Neglected Tropical
DiseasesIgor José dosSantos NascimentoRicardo Olímpiode MouraJanuary2023CMC-SII20220810-01.pdfCMC-SII20220729-01The role of the substance P/neurokinin-1 receptor system in human pathology: focus on
cancer researchRafael CoveñasRodríguezJanuary2023CMC-SII20220729-01.pdfCMC-SII20220308-01Pharmacological intervention of Neurodegenerative diseases: novel approaches SergeyBachurinMarch2021CMC-SII20220308-01.pdfCMC-SII20210714-01Kinase Inhibitors In Drug DiscoveryVikasSharmaSeptember2021CMC-SII20210714-01.pdfCMC-SII20210607-01Nutraceuticals: from basic research to clinical
evidenceDomenicoTrombettaSeptember2021CMC-SII20210607-01.pdfCMC-SII20210311-01Current intellectual glance over nanoparticles in
cancer and neurodegenerative researchMohammad AmjadKamalNigel HGreigBairongShenTanimaBhattacharyaAugust2021CMC-SII20210311-01.pdfCMC-SII20210311-01Biomarkers and emerging drug targets in
neuropsychiatryDonatellaMarazzitiOctober2021CMC-SII20210311-01.pdfCMC-SII20210208-01Retinal degeneration: molecular mechanisms and
therapeutic strategiesXinhuaShuLingZhuSeptember2021CMC-SII20210208-01.pdfCMC-SII20210208-05Synthetic and biological procedures in antiviral
strategy: the present and the futureRaffaeleSALADINODecember2020CMC-SII20210208-05.pdfCMC-SII20210208-04Gut microbiota and chronic diseases and conditionsLauraFranzaRossellaCianciFebruary2021CMC-SII20210208-04.pdfCMC-SII20210208-03Natural product therapy on inflammation-associated
diseases by targeting NOD-like receptor protein 3 (NLRP3)
inflammasome: opportunity and challengeKangXuChararehPourzandJune2021CMC-SII20210208-03.pdfCMC-SII20210208-02Pathophysiological mechanisms of Cerebrovascular
diseasesBersanoAnnaMay2021CMC-SII20210208-02.pdfCMC-SII20210208-01Nucleoside and nucleotide analogues as potential
therapeuticsRozaPawlowskaArkadiuszChworosMarch2022CMC-SII20210204-01.pdfCMC-SII20210208-01Retinal degeneration: molecular mechanisms and
therapeutic strategiesXinhuaShuLingZhuFebruary2020CMC-SII20210204-01.pdfCMC-SII20210204-02Vascular aging and strokeChristosSavopoulosApril2020CMC-SII20210204-02.pdfCMC-SII20201106-01Organometallic and Coordination Complexes: Rational
design and fine-tuning of metalligand systems aimed at
versatile application in MedicineEduardoSobarzo-SánchezMarianela SaldíasPérezJune2021CMC-SII20201106-01.pdfCMC-SII20200914-01Trends in computational approaches for anti-cancer
researchMohammad AmjadKamalBairongShenWaseemHassanOctober2020CMC-SII20200914-01.pdfCMC-SII20200619-04Recent advances in the synthesis and biological
applications of metal/ metal oxidesDr. LalthazualaRokhumOctober2020CMC-SII20200619-04.pdfCMC-SII20200619-03The Role of PCSK9 in Atherogenesis and Inflammatory
DiseasesFabrizioMontecuccoFedericoCarboneOctober2020CMC-SII20200619-03.pdfCMC-SII20200619-02Targeting Cellular Signaling Pathways in Cancer by
Natural CompoundsMohammad AmjadKamalMd. AsaduzzamanKhanOctober2020CMC-SII20200619-02.pdfCMC-SII20200619-01Intelligent Platforms for Drug Design and
DevelopmentXiantingDingMay2020CMC-SII20200619-01.pdfCMC-SII20200612-02Computational Methods and Resources in Biological
and Medical DataHaoLinJanuary2021CMC-SII20200612-02.pdfCMC-SII20200612-01Cytokines in the Genesis and Treatment of
Autoimmune DiseasesAliYadollahpourMylesJonesJune2020CMC-SII20200612-01.pdfCMC-SII20200108-01Artificial Intelligence in Medicine: Disease
diagnosis, drug development and treatment personalizationJacopoTroisiOctober2020CMC-SII20200108-01.pdfCMC-SII20191001-06Natural Products as a Promising Therapeutic
Strategy to Target Cancer Stem CellsTatjanaStanojkovicJune2020CMC-SII20191001-06.pdfCMC-SII20191001-05Hot Natural Products for the Prevention and
Treatment of Diabetes Mellitus (DM)JelenaPopović-DjordjevićApril2020CMC-SII20191001-05.pdfCMC-SII20190820-01Natural Anti-Inflammatory Compounds as Drug
CandidatesYun-LongWuJanuary2020CMC-SII20190820-01.pdf